Keyphrases
TNF-α Antagonists
100%
Constipation
71%
Functional Constipation
58%
BBSRC
57%
Pathfinder
57%
Market Assessment
50%
Patent Landscape Analysis
50%
Technology Market
50%
Age-related
29%
Anti-TNF Drugs
28%
Immune System
22%
Animal Health
22%
Mouse Model
15%
Etanercept
15%
Potential Market
14%
Licensee
14%
Market Research
14%
Route of Administration
14%
Pet Owners
14%
Fund Project
14%
Consumer Health
14%
Elderly Women
8%
Disease Entity
8%
Ulcerative Colitis
8%
Drug Type
8%
Causes of Change
8%
Individual Quality of Life
8%
Long-term Treatment
8%
Pfizer
8%
Number of Patients
8%
Well-defined
8%
Bowel
8%
Aging Effect
8%
Biological Products
8%
Aging
8%
Disease Conditions
8%
University of Brighton
8%
Fecal Output
8%
Etiology
8%
Rheumatoid Arthritis
8%
One Year Period
8%
Human Health
8%
Age-related Changes
8%
Elderly Patients
8%
Health Care Costs
8%
Aged Mice
8%
Medical Assistance
8%
Elderly People
8%
Primary Market
7%
Subcutaneous Injection
7%
IP Strategy
7%
Companion Animals
7%
Anti-TNF Treatment
7%
Potential Partner
7%
Freedom to Operate
7%
Home Remedies
7%
Treatment Drugs
7%
Aged Mouse Model
7%
Difficult to Manage
7%
Competition Analysis
7%
Commercial Companies
7%
Market Sector
7%
Comprehensive Assessment
7%
Human Animals
7%
Pharmaceutical Drugs
7%
Nutraceuticals
7%
Collaborative Research
7%
Stakeholder Perceptions
7%
Potential Alternatives
7%
Barriers to Adoption
7%
Suppression Effect
7%
Market Demand
7%
Care Homes
7%
Unmet
7%
Anti-tumor Necrosis Factor (anti-TNF)
7%
Healthcare Professionals
7%
Drug Administration
7%
Effective Management
7%
Market Analysis
7%
Effective Approach
7%
Market Pull
7%
Routes to Market
7%
Secondary Market
7%
Route Map
7%
Over-the-counter
7%
Best Route
7%
Treatment Options
7%
Tumor Necrosis Factor-α
7%
Therapeutic Approaches
7%
Biopharmaceuticals
7%
Short-term Treatment
7%
Unique Selling Proposition
7%
Effective Treatment
7%
Market Requirements
7%
Mode of Delivery
7%
Funded Research
7%
Treatment Regime
7%
Health Sector
7%
Intellectual Property
7%
Market Needs
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Constipation
71%
Chronic Constipation
58%
Pet Animal
28%
Disease
23%
Mouse Model
22%
Etanercept
15%
Ulcerative Colitis
8%
Rheumatoid Arthritis
8%
Inflammatory Arthritis
8%
Subcutaneous Injection
7%
Drug Administration
7%
Route of Administration
7%
Functional Food
7%
Medicine and Dentistry
Constipation
50%
Tumor Necrosis Factor
50%
Disease
16%
Etanercept
8%
Ulcerative Colitis
8%
Elderly Patient
8%
Biological Molecule
8%
Health Care Cost
8%
Immune System
8%
Rheumatoid Arthritis
8%
Chronic Constipation
8%
Quality of Life
8%
Drug Therapy
8%
Animal Health
8%
Lifespan
8%
Inflammatory Arthritis
8%